PRJNA445447
Disruption of TET-2 promotes the therapeutic efficacy of CD19-targeted T-cells
DNA sequencing data supporting the manuscript 'Disruption of TET-2 promotes the therapeutic efficacy of CD19-targeted T-cells'. Sequencing samples include, integration site analysis, chimeric transcripts, and targeted allele sequencing.